Patheon

Patheon Inc. provides commercial manufacturing and pharmaceutical development services to the pharmaceutical and biotechnology industries

Patheon Inc. provides commercial manufacturing and pharmaceutical development services to the pharmaceutical and biotechnology industries worldwide. Its commercial manufacturing activities relate primarily to prescription and over-the-counter products in solid, semi-solid, liquid, and sterile dosage forms. The company also provides a range of specialized pharmaceutical development capability, including high-potency, sterile, lyophilization, and controlled-release. Patheon delivers products to approximately 120 countries and offers an array of services, including manufacturing, logistics, and packaging of conventional dosage forms, sterile dosage forms, and specialized products. Its contract pharmaceutical development services include pre-formulation, formulation and development of dosage forms; development of analytical methods; manufacture to customer specifications of proposed new drug products during the regulatory drug approval process, including the manufacture of pilot batches; clinical packaging; and scale-up and technology transfer services to validate commercial-scale drug manufacturing processes. The company was founded in 1974 and is based in Mississauga, Canada.